We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
58 hedge funds and large institutions have $165M invested in ADMA Biologics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
92% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 12
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
44% more capital invested
Capital invested by funds: $115M → $165M (+$50.3M)
5% more funds holding
Funds holding: 55 → 58 (+3)
2.41% more ownership
Funds ownership: 55.09% → 57.5% (+2.4%)
Holders
58
Holders Change
+3
Holders Change %
+5.45%
% of All Funds
1.33%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
8
Increased
23
Reduced
12
Closed
5
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$5K
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$6.99M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$1.67M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$1.42M |
| 4 |
Renaissance Technologies
New York
|
+$916K |
| 5 |
JP Morgan Chase
New York
|
+$466K |
Top Sellers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$3.75M |
| 2 |
Millennium Management
New York
|
-$1.03M |
| 3 |
6CM
683 Capital Management
New York
|
-$461K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$226K |
| 5 |
SIM
Spark Investment Management
New York
|
-$168K |
